Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis

BACKGROUND: For patients with MS, medication switches increase the risk of disease reactivation. OBJECTIVE: Compare discontinuation rates due to treatment failure or side effects between teriflunomide and dimethyl fumarate, and investigate clinical variables affecting discontinuation rates. METHODS:...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mult Scler J Exp Transl Clin
Egile Nagusiak: Norborg, Hilde, Riise, Trond, Myhr, Kjell-Morten, Grytten, Nina, Wergeland, Stig
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2021
Gaiak:
Original Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8209840/
https://ncbi.nlm.nih.gov/pubmed/34188949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20552173211022027
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak